Janux Therapeutics, Inc. JANX 深 沪
已收盘 09-20 16:00:00 美东时间
50.20
+0.220
+0.44%
华盛通- 最 高52.23
- 今 开49.98
- 成交量 171.77万股
- 最 低 49.305
- 昨 收 49.98
- 总市值 25.93亿
- 52周最高 65.60
- 市盈率 静 --
- 换手率 3.33%
- 52周最低 5.65
- 委 比 3.36%
- 总股本 5166.01万
- 历史最高 65.60
- 量 比 3.10
- 振 幅 5.85%
- 历史最低 5.65
- 每 手 1
- 风险率 18.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Navigating 5 Analyst Ratings For Janux Therapeutics
In the latest quarter, 5 analysts provided ratings for Janux Therapeutics (NASD...
09-07 00:00
Janux initiated at Stifel with Buy on upcoming data update
Janux Therapeutics (NASDAQ:JANX) traded higher on Friday after Stifel initiated its coverage with a buy recommendation, citing a trial readout for its prostate cancer therapy JANX007 that the cancer d...
09-06 22:06
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing (CORRECTED)
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins.
08-03 02:06
Janux Therapeutics Announces Board of Directors Reshuffle
Janux Therapeutics Inc (JANX) has provided an update. Janux Therapeutics, Inc. ...
07-23 05:27
Small-cap, buy-rated stocks with positive estimate revision factors - BofA
BofA Securities analysts listed buy-rated Russell 2000 (NYSEARCA:IWM) stocks that are in the top quintile of two positive revisions factors. Profits recovery for small caps in 2024 has been pushed int...
06-26 02:07
Ambarella Posts Upbeat Results, Joins Gap, PagerDuty, Elastic And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Nasdaq Composite falling around 1% on Friday. ...
05-31 22:40
美股周涨跌榜 | 一周飙涨80%！诺瓦瓦克斯股价跳升引发轧空，空头巨亏2.5亿美元
一周飙涨80%！诺瓦瓦克斯医药股价跳升引发轧空，空头巨亏2.5亿美元；Blue Bird周涨37.7%股价创历史新高，巴克莱上调目标价>>
05-11 15:16
Wedbush Maintains Outperform on Janux Therapeutics, Raises Price Target to $74
Wedbush analyst Robert Driscoll maintains Janux Therapeutics (NASDAQ:JANX) with a Outperform and raises the price target from $53 to $74.
05-08 22:43
Janux Therapeutics GAAP EPS of -$0.30 beats by $0.03
Janux Therapeutics press release (NASDAQ:JANX): Q1 GAAP EPS of -$0.30 beats by $0.03. As of March 31, 2024, Janux reported cash and cash equivalents and short-term investments of $651.8 million compar...
05-08 05:59
Janux Therapeutics Q1 EPS $(0.30) Beats $(0.33) Estimate, Sales $1.25M Beat $760.00K Estimate
Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 28.57 percent increase over losses of $(0.42) per share from
05-08 04:49
